Dr. Syeda Ali, MD

NPI: 1528051984
Total Payments
$447.58
2024 Payments
$110.89
Companies
8
Transactions
15
Medicare Patients
1,978
Medicare Billing
$866,631

Payment Breakdown by Category

Food & Beverage$427.96 (95.6%)
Education$19.62 (4.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $427.96 14 95.6%
Education $19.62 1 4.4%

Top Paying Companies

Company Total Records Latest Year
Relypsa, Inc. $119.85 1 $0 (2018)
AstraZeneca Pharmaceuticals LP $90.59 4 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $69.60 3 $0 (2024)
Amgen Inc. $48.45 2 $0 (2019)
Otsuka America Pharmaceutical, Inc. $45.20 2 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $31.15 1 $0 (2023)
Mallinckrodt Hospital Products Inc. $30.46 1 $0 (2024)
Noden Pharma USA Inc $12.28 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $110.89 4 Mallinckrodt Hospital Products Inc. ($30.46)
2023 $71.80 3 Bayer Healthcare Pharmaceuticals Inc. ($40.65)
2022 $16.50 1 AstraZeneca Pharmaceuticals LP ($16.50)
2020 $24.20 1 AstraZeneca Pharmaceuticals LP ($24.20)
2019 $50.77 2 Amgen Inc. ($29.24)
2018 $141.93 2 Relypsa, Inc. ($119.85)
2017 $31.49 2 Amgen Inc. ($19.21)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/07/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $23.12 General
Category: NEPHROLOGY
10/30/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $28.95 General
Category: Cardio-renal
09/25/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $28.36 General
Category: Cardiovascular and Metabolism
07/18/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $30.46 General
Category: CRITICAL CARE
12/12/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $31.15 General
Category: DIABETES
06/22/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.03 General
Category: Cardio-renal
06/22/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Education In-kind items and services $19.62 General
Category: Cardio-renal
10/26/2022 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.50 General
Category: Cardiovascular and Metabolism
09/16/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $24.20 General
Category: Cardiovascular and Metabolism
04/17/2019 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $29.24 General
Category: Nephrology
04/11/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $21.53 General
Category: Cardiovascular and Metabolism
10/08/2018 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $119.85 General
Category: Hyperkalemia
09/26/2018 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.08 General
Category: NEPHROLOGY
10/10/2017 Noden Pharma USA Inc Tekturna (Drug) Food and Beverage In-kind items and services $12.28 General
Category: Hypertension
08/22/2017 Amgen Inc. Sensipar (Drug) Food and Beverage In-kind items and services $19.21 General
Category: Nephrology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 453 1,415 $314,540 $192,321
2022 10 514 1,680 $316,895 $224,692
2021 8 482 1,730 $329,210 $224,946
2020 9 529 1,913 $376,675 $224,673
Total Patients
1,978
Total Services
6,738
Medicare Billing
$866,631
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 27 242 $99,900 $69,767 69.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 111 489 $53,790 $43,071 80.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 146 399 $71,400 $41,941 58.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 64 84 $17,360 $12,372 71.3%
90937 Hemodialysis procedure requiring repeated evaluation Facility 2023 37 117 $38,025 $10,192 26.8%
99291 Critical care, first 30-74 minutes Facility 2023 22 38 $19,000 $6,875 36.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 32 32 $11,175 $6,092 54.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 14 14 $3,890 $2,011 51.7%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 32 294 $102,900 $82,817 80.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 146 627 $68,970 $55,126 79.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 138 431 $61,870 $43,242 69.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 91 112 $23,135 $18,443 79.7%
90937 Hemodialysis procedure requiring repeated evaluation Facility 2022 41 123 $39,975 $11,102 27.8%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 14 24 $7,200 $5,804 80.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 17 17 $4,905 $3,120 63.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 12 12 $2,640 $1,751 66.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 12 12 $3,200 $1,648 51.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 11 28 $2,100 $1,638 78.0%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 31 288 $100,800 $81,510 80.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 127 636 $69,960 $56,572 80.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 142 461 $63,200 $45,689 72.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 79 100 $20,300 $16,415 80.9%
90937 Hemodialysis procedure with repeated evaluations Facility 2021 49 178 $57,850 $16,183 28.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 11 17 $8,500 $3,211 37.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 23 30 $4,200 $2,760 65.7%

About Dr. Syeda Ali, MD

Dr. Syeda Ali, MD is a Nephrology healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528051984.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syeda Ali, MD has received a total of $447.58 in payments from pharmaceutical and medical device companies, with $110.89 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($427.96).

As a Medicare-enrolled provider, Ali has provided services to 1,978 Medicare beneficiaries, totaling 6,738 services with total Medicare billing of $866,631. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Pasadena, CA
  • Active Since 08/31/2005
  • Last Updated 07/08/2007
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1528051984

Products in Payments

  • Veltassa (Drug) $119.85
  • Kerendia (Drug) $69.60
  • LOKELMA (Drug) $45.73
  • JYNARQUE (Drug) $45.20
  • FARXIGA (Drug) $44.86
  • JARDIANCE (Drug) $31.15
  • TERLIVAZ (Drug) $30.46
  • Parsabiv (Biological) $29.24
  • Sensipar (Drug) $19.21
  • Tekturna (Drug) $12.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Pasadena